Previous 10 | Next 10 |
Twist Bioscience (TWST) has priced its public offering of ~2.8M common shares at $110.00/share, which consists of ~2.73M shares to be sold by Twist and 75K by certain selling stockholders.The gross proceeds are expected to be ~$300M (from $250M).Underwriters' over-allotment is an additional 4...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the pricing of an underwritten public offering of 2,802,272 shares of its common stock at a price to the pu...
Twist Bioscience (TWST) to offer up to $250M of shares of its common stock and certain selling stockholders intend to offer 75k in the offering. Underwriters have an option to purchase up to $37.5M of shares of its common stock offered by it in the public offering. For further details ...
Looking For Top Health Care Stocks To Buy This Week? 3 To Watch. Health care stocks are flourishing in the stock market this year. This is no surprise given the state of the world right now. With the coronavirus pandemic showing no signs of stopping, the demand for healt...
These stocks look ripe for a 2021 breakout. Seeking Alpha Top Stocks makes it easy to find the strongest stocks in the market. The Ratings give us an advantage to know which companies are positioned better than their peers. For further details see: These Stocks Are Ready...
The following slide deck was published by Twist Bioscience Corporation in conjunction with their 2020 Q4 earnings call. For further details see: Twist Bioscience Corporation 2020 Q4 - Results - Earnings Call Presentation
Image source: The Motley Fool. Twist Bioscience Corp (NASDAQ: TWST) Q4 2020 Earnings Call Nov 23, 2020 , 8:00 a.m. ET Operator Continue reading For further details see: Twist Bioscience Corp (TWST) Q4 2020 Earnings Call Transcript
Twist Bioscience Corporation (TWST) Q4 2020 Earnings Conference Call November 23, 2020 8:00 AM ET Company Participants Jim Thorburn - CFO Emily Leproust - CEO Conference Call Participants Tycho Peterson - JPMorgan Doug Schenkel - Cowen Catherine Schulte - Baird Vijay Kumar - Evercore ISI Pune...
Twist Bioscience (TWST): Q4 GAAP EPS of -$0.54 beats by $0.14.Revenue of $32.43M (+106.0% Y/Y) beats by $9.77M.Press Release For further details see: Twist Bioscience EPS beats by $0.14, beats on revenue
-- Fiscal 2020 Revenues of $90.1M; Increase of 66% over $54.4M in Fiscal 2019 -- -- Strong Growth in Synthetic Biology, NGS Businesses -- -- Twist Biopharma Established 13 Partnerships, 8 with Milestones and/or Royalties in FY20 -- -- Expect Revenue of $110M to $118M for Fis...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...